Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases

Clinical trial NCT05866432 · RECRUITING

Trial details

NCT number: NCT05866432
Sponsor: Medical University of Vienna
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Stage IV

Start date: 2023-07-01
Primary completion: 2026-05-23
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.